Urogen Pharma patents expiration
1. Jelmyto patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9040074 | UROGEN PHARMA | Material and method for treating internal cavities |
Jan, 2031
(7 years from now) | |
| US9950069 | UROGEN PHARMA | Material and method for treating internal cavities |
Jan, 2031
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Apr 15, 2027 |
| New Product (NP) | Apr 15, 2023 |
Drugs and Companies using MITOMYCIN ingredient
Market Authorisation Date: 15 April, 2020
Treatment: NA
Dosage: POWDER;PYELOCALYCEAL
More Information on Dosage
JELMYTO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic